Sponsored By

Advisory Panel Green Lights Heart Device

A device that freezes part of the heart in order to stop abnormal heart rhythms has been recommended for approval by an FDA advisory panel, the Associated Press reports. The Cardiac Cryoablation System from Cryocor Corp. (San Diego) uses a catheter to send nitrous oxide into part of the heart. The nitrous oxide freezes tissues and creates lesions in the upper chamber that ablate areas responsible for the abnormal rhythms.

June 28, 2007

1 Min Read
Advisory Panel Green Lights Heart Device

Similar technologies are available that use radiofrequency energy instead of cold. The panel recommended that the company create a patient registry and conduct follow-up studies. The agency usually, but not always, follows the advice of its panels.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like